Melanoma News and Research

Latest Melanoma News and Research

Study findings may have critical implications to boost efficacy of T cell-based therapies

T lymphocytes found in tumors and implicated in killing tumor cells cope with the shortage of oxygen and nutrients in the tumor microenvironment by using fat as the main source of energy.

11 Sep 2017

Study identifies late effects that may interfere with work status of young adult cancer survivors

Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, is working to educate the public about hereditary cancer risk assessment and testing during Prostate Cancer Awareness Month this September.

11 Sep 2017

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to late-breaking results from the COMBI-AD trial presented today at the ESMO 2017 Congress in Madrid and published in the New England Journal of Medicine.

11 Sep 2017

Combination treatment provides positive results for people with advanced melanoma

In a two-year UCLA-led study, nearly two-thirds of people with advanced melanoma responded positively to a treatment that combines the immunotherapy drug pembrolizumab with a herpes virus called talimogene laherpareovec, or T-VEC.

8 Sep 2017

Generic drug used to increase blood flow may improve effectiveness of cancer immunotherapy

Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.

7 Sep 2017

Study describes link between key melanoma signaling pathway and novel class of drugs

Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.

7 Sep 2017

BUSM researchers show new way to reduce skin cancer risk in redheads

Red-haired people are known for pale skin, freckles, poor tanning ability and unfortunately, an increased risk for developing skin cancer.

6 Sep 2017

Combined PET/CT scanning could identify melanoma patients' response to ICI therapy

Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.

6 Sep 2017

Melanomas mostly from from new spots rather than existing ones

According to a new study appearing this week in the Journal of the American Academy of Dermatology, melanomas do not grow from existing moles and skin growths, but from new ones. Therefore it is vital that people keep a careful eye for new growths over their skin in order to detect early stages of melanomas.

29 Aug 2017

Vast majority of melanoma appears on the skin as new spots, say researchers

As the summer draws to a close, it's time to start putting away flip-flops, bathing suits and beach bags. But as the seasonal supplies disappear into the back of the closet, sunscreen should stay within arm's reach for year-round protection against the sun's ultraviolet rays.

29 Aug 2017

Scientists develop new chimeric antibody to treat malignant cancers in dogs

Scientists have developed a new chimeric antibody that suppresses malignant cancers in dogs, showing promise for safe and effective treatment of intractable cancers.

26 Aug 2017

NIH grant for CWRU professors could enable new directions for cancer immunotherapies

Nicole Steinmetz, PhD, Associate Professor of Biomedical Engineering, Radiology, member of the Case Comprehensive Cancer Center and the Center for RNA Science and Therapeutics in the Division of General Medical Sciences at Case Western Reserve University School of Medicine and the holder of the George J. Picha Designated Professor in Biomaterials, has received a major grant from the National Institutes of Health to help understand how a virus-like particle from plants stimulates potent anti-tumor responses.

26 Aug 2017

New international research project identifies subtypes of ocular melanoma

A new international research project, involving the University of Liverpool's leading eye cancer research group, has identified specific subtypes of ocular melanoma that will help develop improved management strategies and therapies in the future.

23 Aug 2017

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like "breakthrough," "revolutionary" and "a watershed moment."

23 Aug 2017

New technology employs machine-learning software for early detection of melanoma

New technology being developed by researchers at the University of Waterloo and the Sunnybrook Research Institute is using artificial intelligence (AI) to help detect melanoma skin cancer earlier.

23 Aug 2017

New research suggests cell immortalization as more complicated process than originally thought

A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally thought.

18 Aug 2017

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and "promising durable clinical activity" in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease

16 Aug 2017

Researchers create anti-cancer drugs that can effectively kill 58 types of tumors

Boise State University researchers have created anti-cancer drugs that are effective at killing 58 of the 60 types of tumors found in the National Cancer Institutes NCI-60 panel of cancer cells, which affect nine organ systems in the human body.

14 Aug 2017

Researchers boost antimicrobial and anticancer properties of spider peptides

As antibiotic resistance rises and fears over superbugs grow, scientists are looking for new treatment options.

9 Aug 2017

Melanoma News and Research

Latest Melanoma News and Research

Study findings may have critical implications to boost efficacy of T cell-based therapies

Study identifies late effects that may interfere with work status of young adult cancer survivors

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination treatment provides positive results for people with advanced melanoma

Generic drug used to increase blood flow may improve effectiveness of cancer immunotherapy

Study describes link between key melanoma signaling pathway and novel class of drugs

BUSM researchers show new way to reduce skin cancer risk in redheads

Combined PET/CT scanning could identify melanoma patients' response to ICI therapy

Melanomas mostly from from new spots rather than existing ones

Vast majority of melanoma appears on the skin as new spots, say researchers

Scientists develop new chimeric antibody to treat malignant cancers in dogs

NIH grant for CWRU professors could enable new directions for cancer immunotherapies

New international research project identifies subtypes of ocular melanoma

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

New technology employs machine-learning software for early detection of melanoma

New research suggests cell immortalization as more complicated process than originally thought

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

Researchers create anti-cancer drugs that can effectively kill 58 types of tumors

Researchers boost antimicrobial and anticancer properties of spider peptides

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in